Joint Final Report of EORTC 26951 and RTOG 9402: Phase III Trials With Procarbazine, Lomustine, and Vincristine Chemotherapy for Anaplastic Oligodendroglial Tumors

Clinical trials frequently include multiple end points that mature at different times. The initial report, typically based on the basis of the primary end point, may be published when key planned co-primary or secondary analyses are not yet available. Clinical Trial Updates provide an opportunity to...

Descripción completa

Detalles Bibliográficos
Autores principales: Lassman, Andrew B., Hoang-Xuan, Khê, Polley, Mei-Yin C., Brandes, Alba A., Cairncross, J. Gregory, Kros, Johan M., Ashby, Lynn S., Taphoorn, Martin J.B., Souhami, Luis, Dinjens, Winand N.M., Laack, Nadia N., Kouwenhoven, Mathilde C.M., Fink, Karen L., French, Pim J., Macdonald, David R., Lacombe, Denis, Won, Minhee, Gorlia, Thierry, Mehta, Minesh P., van den Bent, Martin J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2022
Materias:
Clinical Trial Updates
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9362869/
https://www.ncbi.nlm.nih.gov/pubmed/35731991
http://dx.doi.org/10.1200/JCO.21.02543

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9362869/
https://www.ncbi.nlm.nih.gov/pubmed/35731991
http://dx.doi.org/10.1200/JCO.21.02543

Ejemplares similares